The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Forty Seven
Stock and Other Ownership Interests - Forty Seven
Patents, Royalties, Other Intellectual Property - Co-inventor on technologies that have been licensed to Forty Seven Inc
Magrolimab and gemcitabine-cisplatin combination enhance phagocytic elimination of bladder cancer.
 
Bernhard Kiss
Stock and Other Ownership Interests - Forty Seven
 
Anne Kathrin Volkmer
Employment - Forty Seven (I)
Stock and Other Ownership Interests - Forty Seven; Forty Seven (I)
Patents, Royalties, Other Intellectual Property - Forty Seven; Forty Seven (I)
 
Dongdong Feng
Employment - Forty Seven
Stock and Other Ownership Interests - Forty Seven
 
Kelly Marie McKenna
Employment - Forty Seven
Stock and Other Ownership Interests - Forty Seven
Patents, Royalties, Other Intellectual Property - Forty Seven
 
Shirley Mihardja
Employment - Forty Seven
Stock and Other Ownership Interests - Forty Seven
 
Mark Chao
Employment - Forty Seven
Leadership - Forty Seven
Stock and Other Ownership Interests - Forty Seven; Hepatx
Honoraria - D2G Oncology
Consulting or Advisory Role - Chimera Bioengineering
Patents, Royalties, Other Intellectual Property - I am an inventor on several patents from Stanford University that have been licensed to Forty Seven, Inc. I am also an inventor on patents generated from Forty Seven, Inc.
Travel, Accommodations, Expenses - Forty Seven
 
Chris H.M. Takimoto
Employment - Forty Seven
Leadership - Forty Seven
Stock and Other Ownership Interests - Forty Seven; Johnson & Johnson
Consulting or Advisory Role - Biomotiv
Patents, Royalties, Other Intellectual Property - Patent Proposals filed relating to using anti-CD47 antibodies as cancer therapy at my current company of employment, Forty Seven, Inc.
Travel, Accommodations, Expenses - Forty Seven
 
Joseph C Liao
No Relationships to Disclose
 
Jens-Peter Volkmer
No Relationships to Disclose
 
Irving L. Weissman
Leadership - Forty Seven
Stock and Other Ownership Interests - Forty Seven
Consulting or Advisory Role - Forty Seven
Patents, Royalties, Other Intellectual Property - Forty Seven
Expert Testimony - Forty Seven